Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2013; 59(1): 78-83


Protective action of melatonin in experimental glaucoma in rats

Mykheĭtseva IM

    Filatov Institute of eye diseases and tissue therapy, Odessa, Ukraine
DOI: https://doi.org/10.15407/fz59.01.078

Abstract

We explored the melatonin influence on the level of amino acid neurotransmitters of the retina in glaucoma neuropathy in rats. Glaucoma was caused by the prolong systemic introduction of adrenalin. In the study 3 groups were participated: control animals; the model of glaucoma; the model of glaucoma treated with melatonin (M) in the dose 0.1 mg/kg during 1 month. In a vitreous body, as place of retina neuromediator accumulation, free amino acids (AA) were determined with the method of ion-exchange chromatography. It was revealed that in adrenalin-induced glaucoma neuropathy the retina mediator profile was changed, namely, exciting glutamate and aspartate levels were increased and inhibit GABA and glycine levels were decreased, resulting in a rise of excitatory index (EI) by 55%. The disbalance of AA neuromediators to a great extent was normalized by prolonged M introduction. A decrease under M influence of excitatory AA gutamate and aspartate and an increase of inhibitory AA resulted in the decline of EL by 27% when compared to the untreated group. Thus, reduction of excitatory impuls in retina under influence of M can determine its neuroprotective activity in glaucoma neuropathy.

Keywords: melatonin, amino acid mediators, retina, glaucomaneuropathy.

References

  1. Anisimov V.N. Melatonin. Rol' v organizme, prime nenie v klinike. SPb: Sistema, 2007. 40 p.
  2.  
  3. Arushanyan E.B., Arushanyan L.G. Modulyatornie svoistva epifizarnogo melatonina . Probl. endokrinologii. 1991. 37, N 3. p.65-68.
  4.   Miheitseva I.N. Disbalans neirotransmitterov setchatki glaz kris pri eksperimental'noi glaukomnoi neiropatii . Neirofiziologiya. 2011. vip.43, N 5. p.457-459  
  5. Miheitseva I.M. "Sposib modelyuvannya hronichnogo pidvishchennogo vnutrishn'oochnogo tisku u shchuriv ", Patent na korisnu model' N 38446, 2009. Byul. N 1.
  6.  
  7. Miheitseva I.N. Molekulyarnie mehanizmi neirodegeneratsii v patogeneze pervichnoi glaukomi, retino-neiroprotektsiya pri vozdeistvii na nih melatonina. Tavr. mediko-biol. vestnik. 2012. 15, N 3. ch.1(59). p.231-234.
  8.  
  9. Alarma-Estrany P., Pintor J. Melatonin receptor in the eye: location, second messengers and role in ocular physiology / Pharm. Ther. 2007. 113, N 3 P.507-522. CrossRef  
  10. Carter-Dawson L., Crawford M.L., Harwerth R.S. Vitreal glutamate concentration in monkeys with experimental glaucoma . Invest Ophthalmol. Vis. Sci. 2002. 43, N 8 P.2633-2640. PubMed
  11.  
  12. Datta P.C., King M.G. Melatonin: effects on brain and behavior . Neurosci. Biobehav. Rev. 1980. N 4. R.451-458.
  13.  
  14. Hai Huang, Shu-Chen Lee, Xiong-Li Yang Modulation by melatonin of glutamatergic synaptic transmission in the carp retina . J. Physiol. 2005. 569, N 3. P.857-871.  CrossRef PubMed PubMedCentral
  15.  
  16. Lima A.C., Louzada P.R., De Mello F.G., Ferreira S.T. Neuroprotection against Abeta and glutamate toxicity by melatonin: are GABA receptor involved? . Neurotox Res. 2003. N 5. P.323-327.  CrossRef  
  17. Simonneaux V., Ribelayga Ch. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides and other pineal transmitters . Pharmacol. Rev. 2003. 55, N 2. P.325-395. CrossRef PubMed
  18.  
  19. Srinivasan V., Pandi-Perumal S.R., Cardinali D.P. Melatonin in Alzheimer's disease and other neurodegenerative disorders . Behav. Brain Funct. 2006. 2.
  20.   Tang Q., Hu Y., Ca O.Y. Neuroprotective effect of melatonin on retinal ganglion cells in rats . J. Huaznang Univ. Sci. and Technol. 2006. 26, N 2. P.235-237 CrossRef  
  21. Wamsley S., Gabelt T., Dahl D. Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma . Arch. Ophthalmol. 2005. 123, N 1. P.64-70. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.